[1] Theilgaard SA, Buchwald C, Ingeholm P, et al.  Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000[J]. Acta Otolaryngol, 2003, 123(3): 433-439.   doi: 10.1080/00016480310001295
[2]

Rosai J. ROSAI & ACDERMAN外科病理学. 回允中译. 9版. 北京: 北京大学医学出版社, 2006: 316-317.
[3] Bradley PJ, Jones NS, Robertson I.  Diagnosis and management of esthesioneuroblastoma[J]. Curr Opin Otolaryngol Head Neck Surg, 2003, 11(2): 112-118.   doi: 10.1097/00020840-200304000-00009
[4] Thompson L.  World Health Organization classification of tumours: pathology and genetics of head and neck tumours[J]. Ear Nose Throat J, 2006, 85(2): 74-.   doi: 10.1177/014556130608500201
[5]

Hyams VJ. Tumors of the upper respiratory tract and ear//Hyams VJ, Batsakis JG, Michaels L. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology, 1988: 240-248.
[6] Morita A, Ebersold MJ, Olsen KD, et al.  Esthesioneuroblastoma: prognosis and management[J]. Neurosurgery, 1993, 32(5): 706-715.   doi: 10.1227/00006123-199305000-00002
[7] Dias FL, Sa GM, Lima RA, et al.  Patterns of failure and outcome in esthesioneuroblastoma[J]. Arch Otolaryngol Head Neck Surg, 2003, 129(11): 1186-1192.   doi: 10.1001/archotol.129.11.1186
[8] Broich G, Pagliari A, Ottaviani F.  Esthesioneuroblastomas: a general review of the cases published since the discovery of the tumour in 1924[J]. Anticaner Res, 1997, 17(4A): 2683-2706.
[9] Levine PA, Gallagher R, Cantrell RW.  Estehsioneuroblastoma: reflections of a 21-years experience[J]. Laryngoscope, 1999, 109(10): 1539-1543.   doi: 10.1097/00005537-199910000-00001
[10] Walch C, Stammberger H, Unger F, et al.  A new therapy concept in esthesioneuroblastoma[J]. Laryngorhinoo to logie, 2000, 79(12): 743-748.   doi: 10.1055/s-2000-9134
[11] Davis RE, Weissler MC.  Esthesioneuroblastoma and neck metastases[J]. Head Neck, 1992, 14(6): 477-482.   doi: 10.1002/hed.2880140610
[12] Chamberlain MC.  Treatment of intracranial metastatic esthesioneuroblastoma[J]. Cancer, 2002, 95(2): 243-248.   doi: 10.1002/cncr.10679
[13] Kadish S, Goodman M, Wang CC.  Olfactory neuroblastoma: a clinical analysis of 17 cases[J]. Cancer, 1976, 37: 1571-1576.   doi: 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L
[14] Spaulding CA, Kranyak MS, Constable WC, et al.  Esthesioneuroblastoma: a comparison of two treatment eras[J]. Int J Radiat Oncol Biol Phys, 1988, 15(3): 581-590.   doi: 10.1016/0360-3016(88)90298-2
[15] Chao KS, Kaplan C, Simpson JR, et al.  Esthesioneuroblastoma: the impact of treatment modality[J]. Head Neck, 2001, 23(9): 749-757.   doi: 10.1002/hed.1107
[16] Foote RL, Morita A, Ebersold MJ, et al.  Esthesioneuroblastoma: the role of adjuvant radiation therapy[J]. Int J Radiat Oncol Biol Phys, 1993, 27(4): 835-842.   doi: 10.1016/0360-3016(93)90457-7
[17] Dulguerov P, Calcaterra T.  Esthesioneuroblastoma: the UCLA experience 1970-1990[J]. Laryngoscope, 1992, 102(8): 843-849.   doi: 10.1288/00005537-199208000-00001
[18] Polin RS, Sheehan JP, Chenelle AG, et al.  The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience[J]. Neurosurgery, 1998, 42(5): 1029-1037.   doi: 10.1097/00006123-199805000-00045
[19] 赵路军, 高黎, 徐国镇, 等.  嗅神经母细胞瘤的预后因素和治疗结果分析[J]. 中华肿瘤杂志, 2005, 27(9): 561-564.   doi: 10.3760/j.issn:0253-3766.2005.09.015
[20] Diaz EM Jr, Johnigan RH 3rd, Pero C, et al.  Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center[J]. Head Neck, 2005, 27(2): 138-149.   doi: 10.1002/hed.20127
[21] 古庆家, 梁传余.  鼻腔嗅神经母细胞瘤的研究进展[J]. 华西医学, 2003, 18(4): 584-585.   doi: 10.3969/j.issn.1002-0179.2003.04.115
[22] Casiano RR, Numa WA, Falquez AM.  Endoscopic resection ofesthesioneuroblastcma[J]. Am J Rhinol, 2001, 15(4): 271-279.   doi: 10.1177/194589240101500410
[23] 王天友, 王秋萍, 薛飞, 等.  鼻内镜下鼻腔鼻窦嗅神经母细胞瘤切除术(附3例报告)[J]. 医学研究生学报, 2007, 20(2): 217-219.   doi: 10.3969/j.issn.1008-8199.2007.02.032
[24] Monroe AT, Hinerman RW, Amdur RJ, et al.  Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation[J]. Head Neck, 2003, 25(7): 529-534.   doi: 10.1002/hed.10247
[25] Loy AH, Reibel JF, Read PW, et al.  Esthesioneuroblastoma: continued follow-up of a single institution′s experience[J]. Arch Otolaryngol Head Neck Surg, 2006, 132(2): 134-138.   doi: 10.1001/archotol.132.2.134
[26] 王伟芳, 袁伟, 王胜资, 等.  嗅神经母细胞瘤和嗅神经上皮瘤的临床特点和治疗评价[J]. 中国癌症杂志, 2006, 16(6): 487-491.   doi: 10.3969/j.issn.1007-3639.2006.06.017
[27] 艾毅钦, 潘志荣, 扬红波.  鼻腔嗅神经母细胞瘤9例临床分析及文献复习[J]. 临床肿瘤学杂志, 2006, 11(8): 627-628.   doi: 10.3969/j.issn.1009-0460.2006.08.022
[28] Zabel A, Thilmann C, Milker-Zabel S, et al.  The role of stereotactically guided conformal radiotherapy for local tumor control esthesioneuroblastoma[J]. Strahlenther Onkol, 2002, 178(4): l87-191.
[29] Unger F, Walch C, Stammberger H. et al.  Olfactory neuroblastoma(esthesioneuroblastoma): report of six cases treated by a novel combination of endoscopic surgery and radiosurgery[J]. Minim Invasive Neurosurg, 2001, 44(2): 79-84.   doi: 10.1055/s-2001-16000
[30] Kim DW, Jo YH, Kim JH, et al.  Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma[J]. Cancer, 2004, 101(10): 2257-2260.   doi: 10.1002/cncr.20648
[31] Mishima Y, Nagasaki E, Terui Y, et al.  Combination chemotherapy(cyclophosphamide, doxorubicin, and vincristine with continuousinfusion cisplatin and etoposide)and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma[J]. Cancer, 2004, 101(6): 1437-1444.   doi: 10.1002/cncr.20471
[32] Koka VN, Julieron M, Bourhis J, et al.  Aesthesioneuroblastoma[J]. J Laryngol Otol, 1998, 112(7): 628-633.   doi: 10.1017/S0022215100141295